Literature DB >> 17264154

Ribophorin I acts as a substrate-specific facilitator of N-glycosylation.

Cornelia M Wilson1, Stephen High.   

Abstract

The mammalian oligosaccharyltransferase (OST) complex is composed of about eight subunits and mediates the N-glycosylation of nascent polypeptide chains entering the endoplasmic reticulum (ER). The conserved STT3 subunit of eukaryotic OST complexes has been identified as its catalytic centre, yet although many other subunits are equally well conserved their functions are unknown. We used RNA interference to investigate the function of ribophorin I, an ER-translocon-associated subunit of the OST complex previously shown to associate with newly synthesised membrane proteins. We show that ribophorin I dramatically enhances the N-glycosylation of selected membrane proteins and provide evidence that it is not essential for N-glycosylation per se. Parallel studies confirm that STT3 is essential for transferase activity of the complex, but reveal that the two mammalian isoforms are not functionally equivalent when modifying bona fide polypeptide substrates. We propose a new model for OST function where ribophorin I acts as a chaperone or escort to promote the N-glycosylation of selected substrates by the catalytic STT3 subunits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264154     DOI: 10.1242/jcs.000729

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  30 in total

1.  The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation.

Authors:  Seita Tomida; Misaki Takata; Tetsuya Hirata; Masamichi Nagae; Miyako Nakano; Yasuhiko Kizuka
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  A precursor-specific role for Hsp40/Hsc70 during tail-anchored protein integration at the endoplasmic reticulum.

Authors:  Catherine Rabu; Peter Wipf; Jeffrey L Brodsky; Stephen High
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

3.  X-ray structure of a bacterial oligosaccharyltransferase.

Authors:  Christian Lizak; Sabina Gerber; Shin Numao; Markus Aebi; Kaspar P Locher
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

4.  Mechanism of bacterial oligosaccharyltransferase: in vitro quantification of sequon binding and catalysis.

Authors:  Sabina Gerber; Christian Lizak; Gaëlle Michaud; Monika Bucher; Tamis Darbre; Markus Aebi; Jean-Louis Reymond; Kaspar P Locher
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 5.  Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation.

Authors:  Elisabeth Mohorko; Rudi Glockshuber; Markus Aebi
Journal:  J Inherit Metab Dis       Date:  2011-05-26       Impact factor: 4.982

6.  DC2 and keratinocyte-associated protein 2 (KCP2), subunits of the oligosaccharyltransferase complex, are regulators of the gamma-secretase-directed processing of amyloid precursor protein (APP).

Authors:  Cornelia M Wilson; Amandine Magnaudeix; Catherine Yardin; Faraj Terro
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

7.  Oligosaccharyltransferase subunits bind polypeptide substrate to locally enhance N-glycosylation.

Authors:  M Fairuz B Jamaluddin; Ulla-Maja Bailey; Benjamin L Schulz
Journal:  Mol Cell Proteomics       Date:  2014-08-12       Impact factor: 5.911

8.  Comparative structural biology of eubacterial and archaeal oligosaccharyltransferases.

Authors:  Nobuo Maita; James Nyirenda; Mayumi Igura; Jun Kamishikiryo; Daisuke Kohda
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

9.  mu-Opioid receptor cell surface expression is regulated by its direct interaction with Ribophorin I.

Authors:  Xin Ge; Horace H Loh; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2009-03-16       Impact factor: 4.436

10.  Distinct donor and acceptor specificities of Trypanosoma brucei oligosaccharyltransferases.

Authors:  Luis Izquierdo; Benjamin L Schulz; João A Rodrigues; Maria Lucia S Güther; James B Procter; Geoffrey J Barton; Markus Aebi; Michael A J Ferguson
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.